Coya Therapeutics, Inc. Common Stock (COYA) — Financial Flexibility Index
Coya Therapeutics, Inc. Common Stock (COYA) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of $-1.01 Million (operating CF $-1.01 Million minus capex $0.00) represents 0% of total liabilities ($6.92 Million). Also explore net asset growth rate of Coya Therapeutics, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coya Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Coya Therapeutics, Inc. Common Stock across 6 annual periods. Check Coya Therapeutics, Inc. Common Stock (COYA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Coya Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Coya Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see COYA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.55x | $-10.74 Million | $-10.74 Million | $6.92 Million | ▲ +28.1% |
| 2024 | -2.16x | $-10.29 Million | $-10.29 Million | $4.77 Million | ▼ -8.5% |
| 2023 | -1.99x | $-11.19 Million | $-11.19 Million | $5.63 Million | ▼ -361.2% |
| 2022 | -0.43x | $-7.24 Million | $-7.24 Million | $16.79 Million | ▲ +86.9% |
| 2021 | -3.28x | $-3.77 Million | $-3.90 Million | $1.15 Million | ▼ -274.8% |
| 2020 | -0.88x | $-391.26K | $-391.27K | $447.12K | — |